Joanna Pepke‐Żaba

32.0k total citations · 6 hit papers
131 papers, 9.1k citations indexed

About

Joanna Pepke‐Żaba is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Joanna Pepke‐Żaba has authored 131 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Pulmonary and Respiratory Medicine, 75 papers in Cardiology and Cardiovascular Medicine and 28 papers in Genetics. Recurrent topics in Joanna Pepke‐Żaba's work include Pulmonary Hypertension Research and Treatments (118 papers), Cardiovascular Issues in Pregnancy (35 papers) and Cardiovascular Function and Risk Factors (27 papers). Joanna Pepke‐Żaba is often cited by papers focused on Pulmonary Hypertension Research and Treatments (118 papers), Cardiovascular Issues in Pregnancy (35 papers) and Cardiovascular Function and Risk Factors (27 papers). Joanna Pepke‐Żaba collaborates with scholars based in United Kingdom, United States and Germany. Joanna Pepke‐Żaba's co-authors include David P. Jenkins, Karen Sheares, Mark Toshner, Iréne Lang, Nicholas W. Morrell, Andrew J. Peacock, Elaine Soon, Eckhard Mayer, Gérald Simonneau and Gerry Coghlan and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Joanna Pepke‐Żaba

124 papers receiving 8.9k citations

Hit Papers

Inhaled nitric oxide as a cause of selective pulmonary va... 1991 2026 2002 2014 1991 2010 2011 2018 2012 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joanna Pepke‐Żaba United Kingdom 44 7.9k 4.9k 1.6k 1.0k 1.0k 131 9.1k
Norifumi Nakanishi Japan 38 5.9k 0.7× 4.6k 0.9× 1.1k 0.7× 733 0.7× 572 0.6× 116 7.7k
Peter Dorfmüller France 56 8.6k 1.1× 3.7k 0.8× 1.5k 0.9× 591 0.6× 675 0.7× 171 10.7k
Zhi‐Cheng Jing China 39 8.6k 1.1× 5.8k 1.2× 1.6k 1.0× 382 0.4× 696 0.7× 221 10.6k
Laurent Savale France 52 6.6k 0.8× 3.4k 0.7× 1.5k 1.0× 346 0.3× 636 0.6× 251 8.3k
Xavier Jaïs France 62 11.4k 1.4× 6.8k 1.4× 2.6k 1.7× 875 0.8× 707 0.7× 261 12.7k
Ivan M. Robbins United States 42 10.9k 1.4× 7.0k 1.4× 2.2k 1.4× 377 0.4× 806 0.8× 106 12.2k
Ekkehard Grünig Germany 50 9.4k 1.2× 6.7k 1.4× 1.3k 0.8× 318 0.3× 623 0.6× 253 11.5k
Pavel Jansa Czechia 27 4.9k 0.6× 3.8k 0.8× 1.1k 0.7× 728 0.7× 394 0.4× 153 5.5k
Richard N. Channick United States 51 13.0k 1.6× 9.1k 1.9× 2.9k 1.8× 1.5k 1.4× 974 1.0× 222 14.7k
Eckhard Mayer Germany 50 7.1k 0.9× 5.4k 1.1× 1.9k 1.2× 2.0k 1.9× 320 0.3× 188 8.7k

Countries citing papers authored by Joanna Pepke‐Żaba

Since Specialization
Citations

This map shows the geographic impact of Joanna Pepke‐Żaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna Pepke‐Żaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna Pepke‐Żaba more than expected).

Fields of papers citing papers by Joanna Pepke‐Żaba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanna Pepke‐Żaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna Pepke‐Żaba. The network helps show where Joanna Pepke‐Żaba may publish in the future.

Co-authorship network of co-authors of Joanna Pepke‐Żaba

This figure shows the co-authorship network connecting the top 25 collaborators of Joanna Pepke‐Żaba. A scholar is included among the top collaborators of Joanna Pepke‐Żaba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanna Pepke‐Żaba. Joanna Pepke‐Żaba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Newman, Joseph, Hakim Ghani, G. Fischer, et al.. (2025). The Pulmonary Hypertension Global Patient Survey: understanding the experiences and perspectives of patients. ERJ Open Research. 11(6). 297–2025.
2.
Jaïs, Xavier, Victor F. Tapson, Timothy M. Fernandes, et al.. (2025). Diagnosis of chronic thromboembolic pulmonary hypertension. The Journal of Heart and Lung Transplantation. 44(7). S1–S7.
3.
White, R. James, Karim El‐Kersh, Stephan Rosenkranz, et al.. (2024). Treatment With Oral or Inhaled Treprostinil in Patients With Pulmonary Arterial Hypertension and Cardiovascular Comorbidities. CHEST Journal. 167(6). 1746–1758. 1 indexed citations
4.
Kim, Nick H., Richard N. Channick, Marion Delcroix, et al.. (2024). Efficacy and safety of selexipag in patients with inoperable or persistent/recurrent CTEPH (SELECT randomised trial). European Respiratory Journal. 64(4). 2400193–2400193. 3 indexed citations
5.
Sheares, Karen, Mark Toshner, Katherine Bunclark, et al.. (2023). Balloon pulmonary angioplasty outcomes in patients previously treated by pulmonary endarterectomy surgery are inferior to those of inoperable patients. Pulmonary Circulation. 13(3). e12265–e12265. 4 indexed citations
6.
Pepke‐Żaba, Joanna, Katherine Bunclark, Alessandro Ruggiero, et al.. (2023). Cardiac MRI in the assessment of chronic thromboembolic pulmonary hypertension and response to treatment. Thorax. 79(1). 90–97. 2 indexed citations
7.
Howard, Luke, Martin Johnson, David G. Kiely, et al.. (2023). Predictors of outcomes in mild pulmonary hypertension according to 2022 ESC/ERS Guidelines: the EVIDENCE-PAH UK study. European Heart Journal. 44(44). 4678–4691. 20 indexed citations
8.
Barco, Stefano, Frederikus A. Klok, Stavros Konstantinides, et al.. (2019). Sex‐specific differences in chronic thromboembolic pulmonary hypertension. Results from the European CTEPH registry. Journal of Thrombosis and Haemostasis. 18(1). 151–161. 50 indexed citations
9.
Soon, Elaine, Alexi Crosby, Mark Southwood, et al.. (2015). Bone Morphogenetic Protein Receptor Type II Deficiency and Increased Inflammatory Cytokine Production. A Gateway to Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 192(7). 859–872. 117 indexed citations
10.
McCabe, Colm, Stephen Preston, Deepa Gopalan, John Dunning, & Joanna Pepke‐Żaba. (2014). Cardiopulmonary Exercise Testing Suggests a Beneficial Response to Pulmonary Endarterectomy in a Patient with Chronic Thromboembolic Obstruction and Normal Preoperative Pulmonary Hemodynamics. Pulmonary Circulation. 4(1). 137–141. 6 indexed citations
11.
Ling, Yi, Martin Johnson, David G. Kiely, et al.. (2012). Changing Demographics, Epidemiology, and Survival of Incident Pulmonary Arterial Hypertension: Results from the Pulmonary Hypertension Registry of the United Kingdom and Ireland. American Journal of Respiratory and Critical Care Medicine. 186(8). 790–796. 392 indexed citations breakdown →
12.
Condliffe, Robin, Josephine Pickworth, Sara J. Walker, et al.. (2012). Serum Osteoprotegerin is Increased and Predicts Survival in Idiopathic Pulmonary Arterial Hypertension. Pulmonary Circulation. 2(1). 21–27. 20 indexed citations
13.
Mayer, Eckhard, David P. Jenkins, Jaroslav Lindner, et al.. (2011). Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: Results from an international prospective registry. Journal of Thoracic and Cardiovascular Surgery. 141(3). 702–710. 479 indexed citations breakdown →
14.
Soon, Elaine, Alan Holmes, Carmen Treacy, et al.. (2010). Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension. Circulation. 122(9). 920–927. 588 indexed citations breakdown →
15.
Toshner, Mark, Robert Voswinckel, Mark Southwood, et al.. (2009). Evidence of Dysfunction of Endothelial Progenitors in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 180(8). 780–787. 174 indexed citations
16.
Craig, Thelma, Michael Duffy, Murali Shyamsundar, et al.. (2009). BTS/BLF/BALR young investigators symposium. Thorax. 64(Suppl 4). A2–A4. 1 indexed citations
17.
Condliffe, Robin, David G. Kiely, Andrew J. Peacock, et al.. (2008). Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era. American Journal of Respiratory and Critical Care Medicine. 179(2). 151–157. 452 indexed citations
18.
Condliffe, Robin, David G. Kiely, J. Simon R. Gibbs, et al.. (2008). Improved Outcomes in Medically and Surgically Treated Chronic Thromboembolic Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 177(10). 1122–1127. 280 indexed citations
19.
Pepke‐Żaba, Joanna, et al.. (2005). LONG-TERM BENEFITS OF SILDENAFIL TREATMENT ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION. CHEST Journal. 128(4). 161S–161S. 1 indexed citations
20.
Hoeper, Marius M., Nazzareno Galiè, Srinivas Murali, et al.. (2002). Outcome after Cardiopulmonary Resuscitation in Patients with Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 165(3). 341–344. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026